JPWO2021216139A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021216139A5 JPWO2021216139A5 JP2022563366A JP2022563366A JPWO2021216139A5 JP WO2021216139 A5 JPWO2021216139 A5 JP WO2021216139A5 JP 2022563366 A JP2022563366 A JP 2022563366A JP 2022563366 A JP2022563366 A JP 2022563366A JP WO2021216139 A5 JPWO2021216139 A5 JP WO2021216139A5
- Authority
- JP
- Japan
- Prior art keywords
- medicament
- kinase inhibitor
- rho kinase
- patient
- alzheimer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003590 rho kinase inhibitor Substances 0.000 claims description 16
- 208000024827 Alzheimer disease Diseases 0.000 claims description 12
- 230000019771 cognition Effects 0.000 claims description 4
- NGOGFTYYXHNFQH-UHFFFAOYSA-N fasudil Chemical group C=1C=CC2=CN=CC=C2C=1S(=O)(=O)N1CCCNCC1 NGOGFTYYXHNFQH-UHFFFAOYSA-N 0.000 claims description 4
- 229960002435 fasudil Drugs 0.000 claims description 4
- 230000000694 effects Effects 0.000 claims description 2
- 239000012729 immediate-release (IR) formulation Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims 13
- 238000000034 method Methods 0.000 description 16
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 1
- 230000007370 cognitive improvement Effects 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 206010027175 memory impairment Diseases 0.000 description 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063014272P | 2020-04-23 | 2020-04-23 | |
US63/014,272 | 2020-04-23 | ||
PCT/US2021/012588 WO2021216139A1 (fr) | 2020-04-23 | 2021-01-08 | Méthodes d'utilisation d'inhibiteurs de la rho kinase pour traiter la maladie d'alzheimer |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023523706A JP2023523706A (ja) | 2023-06-07 |
JPWO2021216139A5 true JPWO2021216139A5 (fr) | 2024-01-11 |
Family
ID=78269840
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022563366A Pending JP2023523706A (ja) | 2020-04-23 | 2021-01-08 | アルツハイマー病を治療するためのrhoキナーゼ阻害剤の使用方法 |
Country Status (7)
Country | Link |
---|---|
US (2) | US20230190765A1 (fr) |
EP (1) | EP4138842A4 (fr) |
JP (1) | JP2023523706A (fr) |
CN (1) | CN115996728A (fr) |
CA (1) | CA3175183A1 (fr) |
MX (1) | MX2022012957A (fr) |
WO (1) | WO2021216139A1 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021194608A1 (fr) * | 2020-03-25 | 2021-09-30 | Woolsey Pharmaceuticals, Inc | Méthodes de traitement de la désorientation spatio-temporelle associée à une protéinopathie |
CA3236462A1 (fr) | 2021-11-29 | 2023-06-01 | Woolsey Pharmaceuticals, Inc. | Procedes de traitement d'agitation et d'autres symptomes comportementaux associes a la demence |
CN115998736B (zh) * | 2023-03-28 | 2023-06-23 | 中国人民解放军军事科学院军事医学研究院 | Y-27632在特异性抑制幻觉作用中的应用 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005117896A1 (fr) * | 2004-06-03 | 2005-12-15 | Schering Aktiengesellschaft | Formulations contenant du fasudil, une matrice et une enveloppe |
US20060212090A1 (en) * | 2005-03-01 | 2006-09-21 | Functional Neuroscience Inc. | Method of treating cognitive disorders using neuromodulation |
JP2010501479A (ja) * | 2006-08-10 | 2010-01-21 | トランスレーショナル ジェノミクス リサーチ インスティテュート | 学習および記憶を改善するための化合物 |
US20110237600A1 (en) * | 2008-05-12 | 2011-09-29 | Amnestix, Inc. | Compounds for improving learning and memory |
DK2825175T3 (da) * | 2012-03-12 | 2017-11-06 | Georg-August-Universität Göttingen Stiftung Öffentlichen Rechts Universitätsmedizin | Rho-kinase-inhibitorer til anvendelse i behandling af amyotrofisk lateral sklerose |
JP2023509970A (ja) * | 2020-01-09 | 2023-03-10 | ウールジー・ファーマシューティカルズ・インコーポレイテッド | 皮質性認知症に関連する徘徊を治療する方法 |
WO2021194608A1 (fr) * | 2020-03-25 | 2021-09-30 | Woolsey Pharmaceuticals, Inc | Méthodes de traitement de la désorientation spatio-temporelle associée à une protéinopathie |
MX2023004523A (es) * | 2020-10-22 | 2023-05-08 | Woolsey Pharmaceuticals Inc | Metodos de tratamiento de tauopatias de 4 repeticiones. |
-
2021
- 2021-01-08 JP JP2022563366A patent/JP2023523706A/ja active Pending
- 2021-01-08 MX MX2022012957A patent/MX2022012957A/es unknown
- 2021-01-08 CN CN202180043725.7A patent/CN115996728A/zh active Pending
- 2021-01-08 CA CA3175183A patent/CA3175183A1/fr active Pending
- 2021-01-08 EP EP21793029.6A patent/EP4138842A4/fr active Pending
- 2021-01-08 WO PCT/US2021/012588 patent/WO2021216139A1/fr unknown
- 2021-01-08 US US17/996,812 patent/US20230190765A1/en active Pending
-
2023
- 2023-02-28 US US18/175,605 patent/US11771704B1/en active Active
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101125462B1 (ko) | 모다피닐의 제약 제제 | |
US4507323A (en) | Treatment of psychosexual dysfunctions | |
US11318144B2 (en) | Compositions and methods for treating Alzheimer's disease and Parkinson's disease | |
JPH02240021A (ja) | 抑うつ障害の治療用に適した制御放出製薬組成物 | |
IL153233A (en) | Extruded rubber structures for reinforcing internal spring assemblies and mattresses | |
JP2002524498A (ja) | 機能性及び/又は器質性痛み症候群の治療のための製薬組成物の調製のためのアセチルコリンエステラーゼ阻害剤の使用 | |
JPH0667841B2 (ja) | 恐慌障害の軽減剤 | |
US6075028A (en) | Method of treating Tourette's syndrome and related CNS disorders | |
WO2021262196A1 (fr) | Compositions et méthodes de traitement de la maladie d'alzheimer et de la maladie de parkinson | |
JPWO2008090736A1 (ja) | アルツハイマー型認知症の予防及び治療のための医薬 | |
JPH0667842B2 (ja) | 基本的うつ病を軽減するためのうつ病治療剤 | |
CN1089474A (zh) | Nadh和nadph作为药物治疗阿耳茨海默氏病 | |
US5897864A (en) | Method for treating sexual dysfunction disorders with compositions containing ginkgo biloba | |
US20050256131A1 (en) | Pharmaceutical active substance combination and the use thereof | |
JPWO2021216139A5 (fr) | ||
RU2003127718A (ru) | Применение флумазенила в производстве лекарственного средства для лечения кокаиновой зависимости | |
IE58734B1 (en) | Use of propiophenone compounds | |
KR100692235B1 (ko) | 안지오텐신 ⅱ 길항물질의 신규한 용도 | |
JP4166955B2 (ja) | ウイルス疾患を処置するためのビュープロピオン | |
AU2001274765A1 (en) | New use of angiotensin II antagonists | |
RU2369393C2 (ru) | Применение окскарбазепина для лечения диабетической нейропатической боли и для улучшения сна | |
US6589996B2 (en) | Treatment of disorders relating to the serotonergic system | |
JPWO2021257122A5 (fr) | ||
JP2024505246A (ja) | 神経変性認知障害を治療するための、コリンエステラーゼ阻害薬と四級アンモニウム抗ムスカリン剤との固定用量配合剤 | |
CA2231557A1 (fr) | Compositions a base de melatonine et d'antalgiques et utilisations |